$CBDL CBD Life Sciences, Inc. (CBDL) Announces Launch of

New Post Public Reply Private Reply Replies (0) Message Board
louied91
288
$CBDL CBD Life Sciences, Inc. (CBDL) Announces Launch of Delta 8 CBD Vape Cartridges

https://www.accesswire.com/885839/cbd-life-sc...cartridges

SCOTTSDALE, AZ / ACCESSWIRE / July 8, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. a pioneering leader in the CBD industry, is excited to announce the launch of their new line of Delta 8 CBD Vape Cartridges. With the introduction of these premium cartridges, available in four tantalizing flavors-Bubba Kush, Watermelon Zkittles, Purple Punch, and Mimosa- CBDL is set to elevate the vaping experience for the customers while delivering unparalleled therapeutic benefits.

Product Highlights:

Delta 8: Each cartridge is infused with high-quality, Delta 8 CBD, ensuring the complete range of beneficial cannabinoids. This formulation maximizes the entourage effect, enhancing the therapeutic benefits and providing a superior vaping experience.

Delicious Flavors: available in four mouth-watering flavors: Bubba Kush, Watermelon Zkittles, Purple Punch, and Mimosa. These flavors not only delight the senses but also offer a unique vaping experience tailored to various preferences.

Premium Quality: CBD Vaults commitment to quality ensures that every cartridge is crafted with the highest standards, using only the finest ingredients and cutting-edge extraction methods.

Key Benefits:

Enhanced Therapeutic Effects: The Delta 8 in the cartridges provides comprehensive wellness benefits, including stress relief, pain management, and improved sleep quality.

Convenience and Discretion: CBDLs sleek and portable cartridges offer a convenient and discreet way to enjoy the benefits of CBD, making them perfect for use on the go.

Innovative Design: Designed for compatibility with standard vape pens, these cartridges ensure a smooth and enjoyable vaping experience.

Revenue and Growth Projections: President & CEO Lisa Nelson states, "Market research indicates a strong demand for high-quality CBD vape products, and we anticipate this new product line will drive significant revenue growth. We project a 50% increase in sales within the first six months of launch, bolstered by our robust marketing strategy and loyal customer base."

Investor Appeal:

Expanding Market: The global CBD market is projected to reach $13.4 billion by 2028, growing at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028. Vape products are among the fastest-growing segments, making CBDLs Delta 8 CBD vape cartridges a strategic entry point into this lucrative market.

Strategic Advantage: CBDLs focus on full-spectrum formulations and premium quality sets them apart from competitors, ensuring a strong market position and customer loyalty.

Sustainable Growth: With a strong pipeline of innovative products, the CBD Vault offers a compelling investment opportunity.

We invite investors to join CBDL on this exciting journey as the company continues to innovate and lead in the CBD industry. Together, we can achieve remarkable success and make a positive impact on the lives of our customers.

CBD Life Sciences Inc. (CBDL) Stock Research Links

CBDL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles